These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26186535)

  • 1. An Extended Polyanion Activation Surface in Insulin Degrading Enzyme.
    Song ES; Ozbil M; Zhang T; Sheetz M; Lee D; Tran D; Li S; Prabhakar R; Hersh LB; Rodgers DW
    PLoS One; 2015; 10(7):e0133114. PubMed ID: 26186535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anion activation site of insulin-degrading enzyme.
    Noinaj N; Song ES; Bhasin S; Alper BJ; Schmidt WK; Hersh LB; Rodgers DW
    J Biol Chem; 2012 Jan; 287(1):48-57. PubMed ID: 22049080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine 904 is required for maximal insulin degrading enzyme activity and polyanion activation.
    Song ES; Melikishvili M; Fried MG; Juliano MA; Juliano L; Rodgers DW; Hersh LB
    PLoS One; 2012; 7(10):e46790. PubMed ID: 23077523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE.
    Im H; Manolopoulou M; Malito E; Shen Y; Zhao J; Neant-Fery M; Sun CY; Meredith SC; Sisodia SS; Leissring MA; Tang WJ
    J Biol Chem; 2007 Aug; 282(35):25453-63. PubMed ID: 17613531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
    Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
    J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inositol phosphates and phosphoinositides activate insulin-degrading enzyme, while phosphoinositides also mediate binding to endosomes.
    Song ES; Jang H; Guo HF; Juliano MA; Juliano L; Morris AJ; Galperin E; Rodgers DW; Hersh LB
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2826-E2835. PubMed ID: 28325868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.
    Shen Y; Joachimiak A; Rosner MR; Tang WJ
    Nature; 2006 Oct; 443(7113):870-4. PubMed ID: 17051221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of interactions of Alzheimer amyloid beta peptides (Abeta40 and Abeta42) with insulin degrading enzyme: a molecular dynamics study.
    Bora RP; Prabhakar R
    Biochemistry; 2010 May; 49(18):3947-56. PubMed ID: 20380468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple allosteric sites are involved in the modulation of insulin-degrading-enzyme activity by somatostatin.
    Tundo GR; Di Muzio E; Ciaccio C; Sbardella D; Di Pierro D; Polticelli F; Coletta M; Marini S
    FEBS J; 2016 Oct; 283(20):3755-3770. PubMed ID: 27579517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the allosteric regulatory site of insulysin.
    Noinaj N; Bhasin SK; Song ES; Scoggin KE; Juliano MA; Juliano L; Hersh LB; Rodgers DW
    PLoS One; 2011; 6(6):e20864. PubMed ID: 21731629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme.
    Malito E; Ralat LA; Manolopoulou M; Tsay JL; Wadlington NL; Tang WJ
    Biochemistry; 2008 Dec; 47(48):12822-34. PubMed ID: 18986166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QM/MM simulations of amyloid-β 42 degradation by IDE in the presence and absence of ATP.
    da Cruz CH; Seabra GM
    J Chem Inf Model; 2015 Jan; 55(1):72-83. PubMed ID: 25539133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulations reveal a novel mechanism for ATP inhibition of insulin degrading enzyme.
    da Cruz CH; Seabra G
    J Chem Inf Model; 2014 May; 54(5):1380-90. PubMed ID: 24697863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the binding of the fluorescent ATP analog TNP-ATP to insulysin.
    Yao H; Hersh LB
    Arch Biochem Biophys; 2006 Jul; 451(2):175-81. PubMed ID: 16723115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
    Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
    Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Determinants of Substrate Specificity in Human Insulin-Degrading Enzyme.
    Stefanidis L; Fusco ND; Cooper SE; Smith-Carpenter JE; Alper BJ
    Biochemistry; 2018 Aug; 57(32):4903-4914. PubMed ID: 30004674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study.
    Grasso G; Rizzarelli E; Spoto G
    J Mass Spectrom; 2009 May; 44(5):735-41. PubMed ID: 19127548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme.
    Çakir B; Dağliyan O; Dağyildiz E; Bariş İ; Kavakli IH; Kizilel S; Türkay M
    PLoS One; 2012; 7(2):e31787. PubMed ID: 22355395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme.
    McCord LA; Liang WG; Dowdell E; Kalas V; Hoey RJ; Koide A; Koide S; Tang WJ
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13827-32. PubMed ID: 23922390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease.
    Fernández-Gamba A; Leal MC; Morelli L; Castaño EM
    Curr Pharm Des; 2009; 15(31):3644-55. PubMed ID: 19925417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.